BR9915729A - Amidas Èmega de n-arilsulfonil-aminoácido - Google Patents
Amidas Èmega de n-arilsulfonil-aminoácidoInfo
- Publication number
- BR9915729A BR9915729A BR9915729-2A BR9915729A BR9915729A BR 9915729 A BR9915729 A BR 9915729A BR 9915729 A BR9915729 A BR 9915729A BR 9915729 A BR9915729 A BR 9915729A
- Authority
- BR
- Brazil
- Prior art keywords
- amino acid
- egamega
- arylsulfonyl
- amides
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
- C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
Abstract
Patente de Invenção: "AMIDAS ÈMEGA DE N-ARILSULFONIL-AMINOáCIDO". Compostos da fórmula (1) e/ou uma forma estereoisómerica do composto da fórmula (1) e/ou um sal fisiologicamente compatível do composto da fórmula (1) são apropriados para a preparação de medicamentos para a terapia e profilaxia de doenças, em cujo decurso participam metaloproteinases-matriz de decomposição.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19851184A DE19851184A1 (de) | 1998-11-06 | 1998-11-06 | N-Arylsulfonyl-aminosäure-omega-amide |
PCT/EP1999/007979 WO2000027808A1 (de) | 1998-11-06 | 1999-10-21 | N-arylsulfonyl-aminosäure-omega-amide |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9915729A true BR9915729A (pt) | 2001-10-23 |
Family
ID=7886902
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9915729-2A BR9915729A (pt) | 1998-11-06 | 1999-10-21 | Amidas Èmega de n-arilsulfonil-aminoácido |
Country Status (23)
Country | Link |
---|---|
US (2) | US6201130B1 (pt) |
EP (1) | EP1124797B1 (pt) |
JP (1) | JP4348014B2 (pt) |
KR (1) | KR100655632B1 (pt) |
CN (1) | CN1206213C (pt) |
AR (1) | AR021086A1 (pt) |
AT (1) | ATE260889T1 (pt) |
AU (1) | AU757602B2 (pt) |
BR (1) | BR9915729A (pt) |
CA (1) | CA2350031C (pt) |
CZ (1) | CZ302291B6 (pt) |
DE (2) | DE19851184A1 (pt) |
DK (1) | DK1124797T3 (pt) |
ES (1) | ES2213405T3 (pt) |
HK (1) | HK1041686B (pt) |
HU (1) | HUP0104122A3 (pt) |
ID (1) | ID28810A (pt) |
PL (1) | PL198827B1 (pt) |
PT (1) | PT1124797E (pt) |
RU (1) | RU2228330C2 (pt) |
TR (1) | TR200101245T2 (pt) |
WO (1) | WO2000027808A1 (pt) |
ZA (1) | ZA200103485B (pt) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PA8557501A1 (es) | 2001-11-12 | 2003-06-30 | Pfizer Prod Inc | Benzamida, heteroarilamida y amidas inversas |
WO2003042190A1 (en) | 2001-11-12 | 2003-05-22 | Pfizer Products Inc. | N-alkyl-adamantyl derivatives as p2x7-receptor antagonists |
US7071223B1 (en) * | 2002-12-31 | 2006-07-04 | Pfizer, Inc. | Benzamide inhibitors of the P2X7 receptor |
PA8591801A1 (es) | 2002-12-31 | 2004-07-26 | Pfizer Prod Inc | Inhibidores benzamidicos del receptor p2x7. |
MXPA05010165A (es) * | 2003-04-15 | 2005-11-16 | Warner Lambert Co | Derivados de prolina biciclicos [c]-condensados y su uso para el tratamiento de estados artriticos. |
CA2525437C (en) * | 2003-05-12 | 2009-04-28 | Pfizer Products Inc. | Benzamide inhibitors of the p2x7 receptor |
BRPI0512651A (pt) * | 2004-06-29 | 2008-03-25 | Pfizer Prod Inc | método para a preparação de derivados de 5-4-(2-hidroxietil)-3,5-dioxo-4,5 dihidro-3h-1,2,4-trizin-2-ila com atividade inibidora de p2x7 por reaçaõ do derivado não substituìdo na posição 4 da trizina com um oxirano na presença de um ácido de lewis |
MXPA06014022A (es) * | 2004-06-29 | 2007-02-08 | Pfizer Prod Inc | Prcedimientos para preparar inhibidores de p2x7. |
CA2572119A1 (en) * | 2004-06-29 | 2006-01-12 | Warner-Lambert Company Llc | Combination therapies utilizing benzamide inhibitors of the p2x7 receptor |
US7576222B2 (en) | 2004-12-28 | 2009-08-18 | Wyeth | Alkynyl-containing tryptophan derivative inhibitors of TACE/matrix metalloproteinase |
AU2006268183B2 (en) | 2005-07-11 | 2012-08-09 | Wyeth | Glutamate aggrecanase inhibitors |
CA2624866A1 (en) | 2005-10-13 | 2007-04-19 | Wyeth | Methods for preparing glutamic acid derivatives |
WO2012004743A1 (en) | 2010-07-09 | 2012-01-12 | Pfizer Limited | Benzenesulfonamides useful as sodium channel inhibitors |
EP2953932B1 (en) * | 2013-02-06 | 2017-03-01 | Merck Patent GmbH | Substituted carboxylic acid derivatives as aggrecanase inhibitors for the treatment of osteoarthritis |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU1063026A1 (ru) * | 1982-05-19 | 1990-12-07 | Институт биохимии АН ЛитССР | N @ -Бензолсульфонильные производные трес-DL-фенилсерина, обладающие противовоспалительной активностью |
JP2764262B2 (ja) | 1987-08-28 | 1998-06-11 | 持田製薬株式会社 | ヒダントイン誘導体及びそれを有効成分とする医薬組成物 |
TW201303B (pt) | 1990-07-05 | 1993-03-01 | Hoffmann La Roche | |
US5455258A (en) * | 1993-01-06 | 1995-10-03 | Ciba-Geigy Corporation | Arylsulfonamido-substituted hydroxamic acids |
GB2303850B (en) | 1994-06-22 | 1998-06-10 | British Biotech Pharm | Metalloproteinase inhibitors |
US5863949A (en) * | 1995-03-08 | 1999-01-26 | Pfizer Inc | Arylsulfonylamino hydroxamic acid derivatives |
JP2000500161A (ja) * | 1995-06-28 | 2000-01-11 | イー・アイ・デユポン・ドウ・ヌムール・アンド・カンパニー | フッ素重合体のナノ複合体 |
KR980009238A (ko) | 1995-07-28 | 1998-04-30 | 우에노 도시오 | 설포닐아미노산 유도체 |
EA001561B1 (ru) * | 1996-05-17 | 2001-04-23 | Варнер-Ламберт Компани | Бифенилсульфонамидные ингибиторы матричных металлопротеиназ |
DE19719621A1 (de) * | 1997-05-09 | 1998-11-12 | Hoechst Ag | Sulfonylaminocarbonsäuren |
-
1998
- 1998-11-06 DE DE19851184A patent/DE19851184A1/de not_active Withdrawn
-
1999
- 1999-10-21 HU HU0104122A patent/HUP0104122A3/hu unknown
- 1999-10-21 TR TR2001/01245T patent/TR200101245T2/xx unknown
- 1999-10-21 DK DK99971799T patent/DK1124797T3/da active
- 1999-10-21 WO PCT/EP1999/007979 patent/WO2000027808A1/de active IP Right Grant
- 1999-10-21 KR KR1020017005590A patent/KR100655632B1/ko not_active IP Right Cessation
- 1999-10-21 CZ CZ20011506A patent/CZ302291B6/cs not_active IP Right Cessation
- 1999-10-21 PL PL347574A patent/PL198827B1/pl not_active IP Right Cessation
- 1999-10-21 CN CNB998129321A patent/CN1206213C/zh not_active Expired - Fee Related
- 1999-10-21 ES ES99971799T patent/ES2213405T3/es not_active Expired - Lifetime
- 1999-10-21 CA CA2350031A patent/CA2350031C/en not_active Expired - Fee Related
- 1999-10-21 ID IDW00200100995A patent/ID28810A/id unknown
- 1999-10-21 RU RU2001115706/04A patent/RU2228330C2/ru not_active IP Right Cessation
- 1999-10-21 PT PT99971799T patent/PT1124797E/pt unknown
- 1999-10-21 AU AU11530/00A patent/AU757602B2/en not_active Ceased
- 1999-10-21 EP EP99971799A patent/EP1124797B1/de not_active Expired - Lifetime
- 1999-10-21 JP JP2000580988A patent/JP4348014B2/ja not_active Expired - Fee Related
- 1999-10-21 AT AT99971799T patent/ATE260889T1/de active
- 1999-10-21 DE DE59908769T patent/DE59908769D1/de not_active Expired - Lifetime
- 1999-10-21 BR BR9915729-2A patent/BR9915729A/pt not_active Application Discontinuation
- 1999-11-04 AR ARP990105584A patent/AR021086A1/es active IP Right Grant
- 1999-11-05 US US09/434,107 patent/US6201130B1/en not_active Expired - Lifetime
-
2000
- 2000-12-28 US US09/749,034 patent/US6335333B1/en not_active Expired - Lifetime
-
2001
- 2001-04-30 ZA ZA200103485A patent/ZA200103485B/en unknown
-
2002
- 2002-05-04 HK HK02103391.7A patent/HK1041686B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CZ20011506A3 (cs) | 2001-08-15 |
KR20010080385A (ko) | 2001-08-22 |
PL198827B1 (pl) | 2008-07-31 |
ATE260889T1 (de) | 2004-03-15 |
AR021086A1 (es) | 2002-06-12 |
PL347574A1 (en) | 2002-04-08 |
HUP0104122A2 (hu) | 2002-03-28 |
KR100655632B1 (ko) | 2006-12-12 |
CN1206213C (zh) | 2005-06-15 |
ID28810A (id) | 2001-07-05 |
RU2228330C2 (ru) | 2004-05-10 |
AU1153000A (en) | 2000-05-29 |
TR200101245T2 (tr) | 2001-10-22 |
CA2350031A1 (en) | 2000-05-18 |
JP4348014B2 (ja) | 2009-10-21 |
EP1124797B1 (de) | 2004-03-03 |
US6335333B1 (en) | 2002-01-01 |
HK1041686B (zh) | 2005-09-23 |
US6201130B1 (en) | 2001-03-13 |
WO2000027808A1 (de) | 2000-05-18 |
CA2350031C (en) | 2010-01-26 |
DK1124797T3 (da) | 2004-07-05 |
JP2002529447A (ja) | 2002-09-10 |
HK1041686A1 (en) | 2002-07-19 |
ZA200103485B (en) | 2001-12-04 |
DE59908769D1 (de) | 2004-04-08 |
PT1124797E (pt) | 2004-07-30 |
ES2213405T3 (es) | 2004-08-16 |
CZ302291B6 (cs) | 2011-02-09 |
AU757602B2 (en) | 2003-02-27 |
DE19851184A1 (de) | 2000-05-11 |
HUP0104122A3 (en) | 2002-04-29 |
CN1332724A (zh) | 2002-01-23 |
EP1124797A1 (de) | 2001-08-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0214757A (pt) | Formulações farmacêuticas de derivados de platina | |
BG104727A (en) | Pharmaceutical composition of topiramate | |
BR9915553A (pt) | Amidas de ácido antranìlico e seu emprego como medicamento | |
BR9915729A (pt) | Amidas Èmega de n-arilsulfonil-aminoácido | |
BR9714082A (pt) | Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto. | |
BR0010498A (pt) | Composições modernas de medicamentos à base de compostos anticolinergicamente ativos e beta-miméticos | |
BR9909565A (pt) | Derivados bicìclicos do ácido hidroxâmico | |
ES2187300A1 (es) | Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos. | |
ECSP034883A (es) | Amidas de acidos antranilicos con cadena lateral de heteroarilsulfonilo, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico, asi como preparados farmaceuticos que las contienen | |
BR9810312A (pt) | Composição farmacêutica que apresenta atividade antitumoral acentuada e/ou efeitos colaterais reduzidos contendo um agente antitumoral e um derivado do ácido hidroxìmico | |
WO2003048164A3 (en) | Adenosine a2a receptor antagonists | |
WO2002018334A3 (en) | Sodium channel modulators | |
TR200101633T2 (tr) | Farmasötik bileşim | |
BRPI0114344B8 (pt) | composto retinóide, seu uso, sua composição farmacêutica e seu processo de preparação | |
DK0583421T3 (da) | Substituerede dibenzoxazepinforbindelser, lægemidler og fremgangsmåder til anvendelse | |
BR0113590A (pt) | 7-oxo-piridopirimidinas | |
DK1383752T3 (da) | Deutererede 3-piperidinopropiophenoner samt lægemidler indeholdende disse forbindelser | |
ID29025A (id) | Fenilalkenoilguanidina-fenilalkenoilguanidina yang disubstitusi asam empedu, proses pembuatannya, penggunaannya sebagai obat atau diaknostik dan obat-obat yang mengandungnya | |
MXPA05013607A (es) | Candidatos de farmaco farmaceuticos mejorados y metodos para preparar los mismos. | |
BR9913337A (pt) | Derivados tan-1057 | |
BR0212249A (pt) | Composto, composição farmacêutica, método de tratamento ou profilaxia de doenças, e, uso de um composto | |
BR0116653A (pt) | Medicamento contendo uma poliamina como substância ativa | |
SE9901572D0 (sv) | New compounds | |
BRPI0512151A (pt) | solução concentrada de sal de sódio monoidratado do tenatoprazol, composição farmacêutica, utilização do sal de sódio monoidratado do tenatoprazol, processo de preparação do sal de sódio monoidratado do tenatoprazol, e composição para administração por via oral do sal de sódio monoidratado do tenatoprazol | |
BR0211223A (pt) | Derivados de 4-aminociclohexanol substituìdos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25D | Requested change of name of applicant approved |
Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) Free format text: ALTERADO DE: AVENTIS PHARMA DEUTSCHLAND GMBH |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFERIMENTO DO PRESENTE PEDIDO, UMA VEZ QUE NAO ATENDE AOS ART. 8O E 13 DA LPI. |
|
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |